A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus

被引：0

作者：

Yang, H. ^{[1
,6
,14
]}

Fu, J. ^{[1
]}

Liu, M. ^{[2
]}

Chen, Y. ^{[3
]}

Chen, Z. ^{[4
]}

Zhu, C. ^{[5
]}

Yang, H. ^{[1
,6
,14
]}

Fang, W. ^{[7
]}

Wang, J. ^{[8
]}

Yu, Z. ^{[9
]}

Pang, Q. ^{[10
]}

Mao, W. ^{[11
]}

Zheng, X. ^{[12
]}

Xiang, J. ^{[13
]}

Yang, H. ^{[1
,6
,14
]}

Han, Y. ^{[15
]}

机构：

[1] Sun Yat Sen Univ, Thorac Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[2] Sun Yat Sen Univ, Radiat Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[3] Shantou Univ, Canc Hosp, Thorac Oncol, Shantou, Peoples R China

[4] Shantou Univ, Canc Hosp, Radiotherapy, Shantou, Peoples R China

[5] Taizhou Hosp Zhejiang Prov, Thorac Oncol, Taizhou, Peoples R China

[6] Taizhou Hosp Zhejiang Prov, Radiotherapy, Taizhou, Peoples R China

[7] Shanghai Chest Hosp, Thorac Surg, Shanghai, Peoples R China

[8] Shanghai Chest Hosp, Radiotherapy, Shanghai, Peoples R China

[9] Tianjin Med Univ, Thorac Oncol, Canc Inst & Hosp, Tianjin, Peoples R China

[10] Tianjin Med Univ, Canc Inst & Hosp, Radiotherapy, Tianjin, Peoples R China

[11] Zhejiang Canc Hosp, Thorac Oncol, Hangzhou, Zhejiang, Peoples R China

[12] Zhejiang Canc Hosp, Radiotherapy, Hangzhou, Zhejiang, Peoples R China

[13] Fudan Univ, Shanghai Canc Ctr, Thorac Oncol, Shanghai, Peoples R China

[14] Fudan Univ, Shanghai Canc Ctr, Radiotherapy, Shanghai, Peoples R China

[15] Sichuan Canc Hosp, Thorac Oncol, Chengdu, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

基金：

美国国家科学基金会;

关键词：

D O I：

10.1093/annonc/mdw371.3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

611O

引用

页数：1

共 50 条

[21] Interpreting the Survival Benefit From Neoadjuvant Chemoradiotherapy Before Surgery for Locally Advanced Squamous Cell Carcinoma of the Esophagus Reply
Li, Jibin
Liu, Qing
Yang, Hong
Fu, Jianhua
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (12) : 1034 - +
[22] Neoadjuvant chemoradiotherapy followed by surgery is associated with better survival outcomes in patients with locally advanced esophageal squamous cell carcinoma
Yoshida, Naoya
Baba, Hideo
JOURNAL OF THORACIC DISEASE, 2018, 10 : S3067 - S3068
[23] Primary Surgery Followed by Selective Chemoradiotherapy Versus Preoperative Chemoradiotherapy Followed by Surgery for Locally Advanced Rectal Cancer: A Randomized Clinical Trial
Li, Jun
Hu, Ye-Ting
Liu, Cheng-Cheng
Wang, Liu-Hong
Ju, Hai-Xing
Huang, Xue-Feng
Chi, Pan
Du, Jin-Lin
Wang, Jian-Ping
Xiao, Yi
Lin, Guo-Le
Zhang, Wei
Zhao, Hong
Liu, Ming
Song, Yong-Mao
Xu, Dong
Wang, Jian-Wei
Sun, Li-Feng
Xie, Hai-Ting
Cao, Hong-Feng
Xiao, Qian
Wang, Jian
Wu, Qing-Bin
Li, De-Chuan
Dai, Sheng
Jiang, Wei-Zhong
Shen, Li
Yuan, Ying
Wang, Zi-Qiang
Ding, Ke-Feng
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 119 (03): : 884 - 895
[24] Neoadjuvant Immunotherapy Combined Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study
Hong, Zhi-Nuan
Weng, Kai
Peng, Kaiming
Chen, Zhen
Lin, Jihong
Kang, Mingqiang
FRONTIERS IN ONCOLOGY, 2021, 11
[25] Problems in neoadjuvant chemoradiotherapy preceding surgery for advanced squamous cell carcinoma of the thoracic esophagus.
Ishida K.
Koeda K.
Sato N.
Ikeda K.
Ohtsuka K.
Aoki K.
Kimura Y.
Iwaya T.
Uesugi N.
Nakamura R.
The Japanese Journal of Thoracic and Cardiovascular Surgery, 1999, 47 (6): : 262 - 266
[26] A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
Huang, Pei-Wei
Lin, Chien-Yu
Hsieh, Chia-Hsun
Hsu, Cheng-Lung
Fan, Kang-Hsing
Huang, Shiang-Fu
Liao, Chun-Ta
Ng, Shu-Kung
Yen, Tzu-Chen
Chang, Joseph Tung-Chieh
Wang, Hung-Ming
BIOMEDICAL JOURNAL, 2018, 41 (02) : 129 - 136
[27] Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
Burmeister, BH
Smithers, BM
Gebski, V
Fitzgerald, L
Simes, RJ
Devitt, P
Ackland, S
Gotley, DC
Joseph, D
Millar, J
North, J
Walpole, ET
Denham, JW
LANCET ONCOLOGY, 2005, 6 (09): : 659 - 668
[28] Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002)
Shang, Xiaobin
Zhang, Wencheng
Zhao, Gang
Liang, Fei
Zhang, Chen
Yue, Jie
Duan, Xiaofeng
Ma, Zhao
Chen, Chuangui
Pang, Qingsong
Zhang, Weihong
Liu, Liang
Ren, Xiubao
Meng, Bin
Zhang, Peng
Ma, Yegang
Zhang, Lin
Li, Hecheng
Kang, Xiaozheng
Li, Yin
Jiang, Hongjing
FRONTIERS IN ONCOLOGY, 2022, 12
[29] Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial
Tang, H.
Wang, H.
Fang, Y.
Zhu, J. Y.
Yin, J.
Shen, Y. X.
Zeng, Z. C.
Xiang, D. X.
Hou, Y. Y.
Du, M.
Lian, C. H.
Zhao, Q.
Jiang, H. J.
Gong, L.
Li, Z. G.
Liu, J.
Xie, D. Y.
Li, W. F.
Chen, C.
Zheng, B.
Chen, K. N.
Dai, L.
Liao, Y. D.
Li, K.
Li, H. C.
Zhao, N. Q.
Tan, L. J.
ANNALS OF ONCOLOGY, 2023, 34 (02) : 163 - 172
[30] Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random
Qian, Dong
Chen, Xi
Shang, Xiaobin
Wang, Yuwen
Tang, Peng
Han, Dong
Jiang, Hongjing
Chen, Chuangui
Zhao, Gang
Zhou, Dejun
Cao, Fuliang
Er, Puchun
Zhang, Wencheng
Li, Xiaoxia
Zhang, Tian
Zhang, Baozhong
Guan, Yong
Wang, Jun
Yuan, Zhiyong
Yu, Zhentao
Wang, Ping
Pang, Qingsong
RADIOTHERAPY AND ONCOLOGY, 2022, 174 : 1 - 7

← 1 2 3 4 5 →